At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change ...

A hot (if cautious) topic at the big gene therapy meeting: what Vinay Prasad's appointment might mean for approvals in rare ...

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene therapies, and blood supply.

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

Vinay Prasad, a critic of the Food and Drug Administration ... at San Francisco professor and epidemiologist, will replace Peter Marks, whom the Trump administration forced out in late March.

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health leadership.

The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.

The U.S. FDA has appointed Vinay Prasad to be the next director of its Center for Biologics Evaluation and Research division (CBER), the agency's Commissioner Martin Makary posted on the social media ...

Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...

The Food and Drug Administration (FDA) has tapped Vinay Prasad ... to lead the agency’s vaccines division. Prasad replaces Peter Marks, the longtime leader of the Center for Biologics Evaluation ...